Deciphering Opioid Peptide Binding Modes at Atypical Chemokine Receptor 3.

Area of Science:

• Pharmacology
• Structural Biology
• Neuroscience

Background:

• The atypical chemokine receptor ACKR3 acts as a scavenger receptor, internalizing ligands like opioid peptides.
• ACKR3's role in endogenous pain management suggests it as a potential target for novel analgesics.
• Structural data for ACKR3 ligand binding is limited, especially for opioid peptides.

Purpose of the Study:

• To structurally model the binding of opioid peptides, specifically adrenorphin and dynorphin A, to ACKR3.
• To compare opioid peptide binding modes at ACKR3 with those at classical opioid receptors (MOR, KOR, DOR).
• To validate the structural model using structure-activity relationships and in vitro experiments.

Main Methods:

• Molecular dynamics simulations
• Pharmacophore analysis
• In vitro mutagenesis studies of ACKR3 and its variant LIH383

Main Results:

• A structural model for opioid peptide binding at ACKR3 was developed.
• The model explains previously observed structure-activity relationships for adrenorphin derivatives.
• In vitro experiments confirmed and strengthened the proposed binding model.

Conclusions:

• The study provides a validated structural model for opioid peptide binding to ACKR3.
• This research lays the foundation for developing new ACKR3-targeting analgesics.
• Understanding ACKR3's ligand binding profile is crucial for future drug development.